CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 72 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-10-29 | Pauls Matthew Director | Grant or award · Stock Option (Right to Buy) | +37,794 | 37,794 | ||
| 2015-06-11 | EMANUELE ROBERT MARTIN Senior VP, Development | Grant or award · Employee Stock Option (Right to Buy) | +291,500 | 291,500 | ||
| 2015-06-11 | Shuster Lewis Director | Grant or award · Stock Option (Right to Buy) | +82,963 | 82,963 | ||
| 2015-06-11 | RAMSAY DAVID A Director | Grant or award · Stock Option (Right to Buy) | +82,963 | 82,963 | ||
| 2015-06-11 | Roberts Brandi Chief Financial Officer & SVP | Grant or award · Employee Stock Option (Right to Buy) | +444,400 | 444,400 | ||
| 2015-06-11 | Parsley Edwin L. Chief Medical Officer & SVP | Grant or award · Employee Stock Option (Right to Buy) | +555,850 | 555,850 | ||
| 2015-06-11 | Culley Brian M CEO and Director | Grant or award · Employee Stock Option (Right to Buy) | +888,900 | 888,900 | ||
| 2015-06-11 | Gorgas Gregory D. Senior VP, Commercial | Grant or award · Employee Stock Option (Right to Buy) | +417,100 | 417,100 | ||
| 2015-06-11 | LIEF JACK Director | Grant or award · Stock Option (Right to Buy) | +82,963 | 82,963 | ||
| 2015-06-11 | DITTRICH HOWARD Director | Grant or award · Stock Option (Right to Buy) | +82,963 | 82,963 | ||
| 2015-03-27 | Roberts Brandi Chief Financial Officer & SVP | Purchase | +18,000 | $0.50 | $9K | 38,000 |
| 2015-03-26 | Roberts Brandi Chief Financial Officer & SVP | Purchase | +20,000 | $0.50 | $10K | 20,000 |
| 2015-01-02 | Gorgas Gregory D. Senior VP, Commercial | Grant or award · Stock Option (Right to Buy) | +622,800 | 622,800 | ||
| 2015-01-02 | EMANUELE ROBERT MARTIN Senior VP, Development | Grant or award · Stock Option (Right to Buy) | +500,250 | 500,250 | ||
| 2015-01-02 | Culley Brian M CEO and Director | Grant or award · Stock Option (Right to Buy) | +2,100,550 | 2,100,550 | ||
| 2015-01-02 | Roberts Brandi Chief Financial Officer & SVP | Grant or award · Stock Option (Right to Buy) | +722,800 | 722,800 | ||
| 2015-01-02 | Keran Patrick L President & COO | Grant or award · Stock Option (Right to Buy) | +2,100,550 | 2,100,550 | ||
| 2015-01-02 | Parsley Edwin L. Chief Medical Officer & SVP | Grant or award · Stock Option (Right to Buy) | +938,300 | 938,300 | ||
| 2014-10-01 | Parsley Edwin L. Chief Medical Officer & SVP | Grant or award · Employee Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2014-06-19 | Shuster Lewis Director | Grant or award · Stock Option (Right to Buy) | +46,609 | 46,609 |
Page 21 of 26 · 505 trades